CATALYST PHARMACEUTICALS INC (CPRX) Stock Analyst Earnings Estimates
NASDAQ:CPRX - Nasdaq - US14888U1016 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 140.8M 18.22% | 214.2M 52.13% | 398.204M 85.90% | 493.18M 23.85% | 575.85M 16.76% | 654.17M 13.60% | 733.07M 12.06% | 800.79M 9.24% | 917.36M 14.56% | 995.34M 8.50% | 1.078B 8.30% | 1.148B 6.49% | |
| EBITDA YoY % growth | 52.6M 27.05% | 103M 95.82% | 119.693M 16.21% | 214.88M 79.53% | 190.87M -11.17% | 177.51M -7.00% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 52.4M 26.88% | 101.8M 94.27% | 86.812M -14.72% | 186.54M 114.88% | 241.41M 29.41% | 299.21M 23.94% | 345.21M 15.37% | 392.27M 13.63% | 532.3M 35.70% | 603.35M 13.35% | 677.64M 12.31% | 740.6M 9.29% | |
| Operating Margin | 37.22% | 47.53% | 21.80% | 37.82% | 41.92% | 45.74% | 47.09% | 48.99% | 58.03% | 60.62% | 62.86% | 64.51% | |
| EPS YoY % growth | 0.37 -9.76% | 0.74 100.00% | 0.81 9.46% | 1.24 53.42% | 1.62 30.37% | 1.98 22.46% | 2.94 48.33% | 3.30 12.13% | 1.64 -50.23% | 1.77 8.07% | 2.19 23.56% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.35 11.87% | 0.30 57.47% | 0.37 11.27% | 0.37 5.88% | 0.43 22.55% |
| Revenue Q2Q % growth | 136.81M 23.73% | 131.15M 33.14% | 144.17M 17.49% | 145.71M 13.22% | 153.95M 12.53% |
| EBITDA Q2Q % growth | 56.105M -24.76% | 45.54M 24.58% | 55.971M -23.44% | 48.692M -38.54% | N/A |
| EBIT Q2Q % growth | 54.51M 30.74% | 47.269M 74.26% | 58.039M 6.99% | 56.791M 11.55% | 68.308M 25.31% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.35 220.69% | 0.31 | 0.04 | 12.87% |
| Q2 2024 Q2Q % growth | 0.33 -37.74% | 0.27 | 0.06 | 22.55% |
| Q1 2024 Q2Q % growth | 0.19 -26.92% | 0.17 | 0.02 | 12.21% |
| Q4 2023 Q2Q % growth | 0.31 40.91% | 0.27 | 0.04 | 14.69% |
| Q3 2023 Q2Q % growth | -0.29 -245.00% | -0.29 | 0.00 | 0.24% |
| Q2 2023 Q2Q % growth | 0.53 165.00% | 0.36 | 0.17 | 45.96% |
| Q1 2023 Q2Q % growth | 0.26 116.67% | 0.33 | -0.07 | -20.84% |
| Q4 2022 Q2Q % growth | 0.22 144.44% | 0.22 | 0.00 | 1.74% |
| Q3 2022 Q2Q % growth | 0.20 100.00% | 0.19 | 0.01 | 3.20% |
| Q2 2022 Q2Q % growth | 0.20 81.82% | 0.17 | 0.03 | 15.34% |
| Q1 2022 Q2Q % growth | 0.12 71.43% | 0.14 | -0.02 | -13.49% |
| Q4 2021 Q2Q % growth | 0.09 -18.18% | 0.12 | -0.03 | -23.94% |
| Q3 2021 Q2Q % growth | 0.10 -9.09% | 0.11 | -0.01 | -5.73% |
| Q2 2021 Q2Q % growth | 0.11 22.22% | 0.10 | 0.01 | 12.34% |
| Q1 2021 Q2Q % growth | 0.07 -30.00% | 0.09 | -0.02 | -23.75% |
| Q4 2020 Q2Q % growth | 0.11 37.50% | 0.09 | 0.02 | 17.22% |
| Q3 2020 Q2Q % growth | 0.11 -15.38% | 0.10 | 0.01 | 12.34% |
| Q2 2020 Q2Q % growth | 0.09 -10.00% | 0.09 | 0.00 | 3.81% |
| Q1 2020 Q2Q % growth | 0.10 1,100.00% | 0.09 | 0.01 | 13.12% |
| Q4 2019 Q2Q % growth | 0.08 | 0.11 | -0.03 | -24.10% |
| Q3 2019 Q2Q % growth | 0.13 | 0.11 | 0.02 | 15.86% |
| Q2 2019 Q2Q % growth | 0.10 | 0.03 | 0.07 | 292.16% |
| Q1 2019 Q2Q % growth | -0.01 | -0.13 | 0.12 | 92.34% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 128.695M 25.33% | 125.89M | 2.805M | 2.23% |
| Q2 2024 Q2Q % growth | 122.71M 23.23% | 114.1M | 8.61M | 7.55% |
| Q1 2024 Q2Q % growth | 98.509M 15.40% | 100.09M | -1.581M | -1.58% |
| Q4 2023 Q2Q % growth | 110.568M 81.86% | 108.04M | 2.528M | 2.34% |
| Q3 2023 Q2Q % growth | 102.688M 79.52% | 102.38M | 308K | 0.30% |
| Q2 2023 Q2Q % growth | 99.582M 87.54% | 93.54M | 6.042M | 6.46% |
| Q1 2023 Q2Q % growth | 85.366M 98.06% | 83.249M | 2.117M | 2.54% |
| Q4 2022 Q2Q % growth | 60.8M 58.75% | 59.252M | 1.548M | 2.61% |
| Q3 2022 Q2Q % growth | 57.2M 58.89% | 54.696M | 2.504M | 4.58% |
| Q2 2022 Q2Q % growth | 53.1M 45.88% | 50.197M | 2.903M | 5.78% |
| Q1 2022 Q2Q % growth | 43.1M 42.72% | 43.61M | -510K | -1.17% |
| Q4 2021 Q2Q % growth | 38.3M 23.55% | 38.955M | -655K | -1.68% |
| Q3 2021 Q2Q % growth | 36M 22.87% | 35.28M | 720K | 2.04% |
| Q2 2021 Q2Q % growth | 36.4M 22.97% | 32.138M | 4.262M | 13.26% |
| Q1 2021 Q2Q % growth | 30.2M 3.78% | 32.742M | -2.542M | -7.76% |
| Q4 2020 Q2Q % growth | 31M 2.99% | 30.957M | 43K | 0.14% |
| Q3 2020 Q2Q % growth | 29.3M -5.18% | 32.124M | -2.824M | -8.79% |
| Q2 2020 Q2Q % growth | 29.6M 2.78% | 30.074M | -474K | -1.58% |
| Q1 2020 Q2Q % growth | 29.1M 134.68% | 32.092M | -2.992M | -9.32% |
| Q4 2019 Q2Q % growth | 30.1M | 29.985M | 115K | 0.38% |
| Q3 2019 Q2Q % growth | 30.9M | 33.844M | -2.944M | -8.70% |
| Q2 2019 Q2Q % growth | 28.8M | 18.862M | 9.938M | 52.69% |
| Q1 2019 Q2Q % growth | 12.4M | 1.632M | 10.768M | 659.80% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 29.77% | 0% | 10.96% |
| Revenue | 0% | 2.98% | -0.11% | 2.08% |